Search Within

Karen Anne Autio

Formats
  1. Meeting Abstract (77)
  2. Journal Article (40)
  3. Review (3)
Groups
  1. Department of Medicine (120)
  2. Genitourinary Oncology Service (120)
  3. Solid Tumor Oncology Division (120)
  4. Hematologic Malignancies, Division of (30)
  5. GSK Faculty (21)
  6. Epidemiology and Biostatistics (14)

More Groups

People
  1. Howard Scher (46)
  2. Michael Morris (36)
  3. Dana Rathkopf (34)
  4. Susan Slovin (28)
  5. Daniel Danila (22)
  6. Wassim Abida (15)

More People

Years
  1. 2025 (5)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Annals of Oncology (18)
  3. Journal for ImmunoTherapy of Cancer (11)
  4. Clinical Cancer Research (8)
  5. Journal of Immunotherapy and Precision Oncology (3)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Oxford University Press (18)
  3. Biomed Central Ltd (11)
  4. American Association for Cancer Research (10)
  5. Elsevier Inc. (5)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (120)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
    Meeting Abstract

    Naing, A.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Patel, M. R.; Wong, D. J.; Falchook, G.; Pant, S.; Whiteside, M.; Rasco, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
    Meeting Abstract

    Naing, A.; Pant, S.; Infante, J.; Papadopoulos, K.; Autio, K.; Wong, D.; Ott, P.; Falchook, G.; Patel, M.; Whiteside, M.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • Safety, antitumor activity, and immune activation of pegylated recombinant human interleukin-10 (AM0010) in patients with advanced solid tumors
    Journal Article

    Naing, A.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Patel, M. R.; Wong, D. J.; Falchook, G. S.; Pant, S.; Whiteside, M.; Rasco, D. R.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Garcia, J. A.; Alva, A. S.; Hart, L. L.; Milowsky, M. I.; Posadas, E. M.; Ryan, C. J.; Summa, J. M.; Youssoufian, H.; Scher, H. I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - A phase I study
    Meeting Abstract

    Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Autio, K. A.; Wong, D. J.; Falchook, G. S.; Patel, M. R.; Pant, S.; Whiteside, M.; Bendell, J.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • PEGylated human IL-10 (AM0010) in advanced solid tumors
    Meeting Abstract

    Naing, A.; Infante, J. R.; Papadopoulos, K.; Autio, K.; Ott, P.; Wong, D.; Falchook, G. S.; Patel, M. R.; Pant, S.; Oft, M.
    Annals of Oncology (2015)

    Fulltext@MSK | Save
  • Safety and anti-tumour activity of pegylated recombinant human IL-10 (Am0010) in selected advanced solid tumours
    Meeting Abstract

    Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Falchook, G.; Wong, D.; Whiteside, M.; Oft, M.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors
    Meeting Abstract

    Infante, J. R.; Naing, A.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Wong, D. J. L.; Falchook, G. S.; Patel, M. R.; Pant, S.; Whiteside, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Presence of myeloid-derived suppressor cells (MDSC) in patients with metastatic castration-sensitive and castration-resistant prostate cancer
    Meeting Abstract

    Autio, K. A.; Wong, P.; Rabinowitz, A.; Yuan, J. D.; Slavin, L. M.; Brennan, R.; DerSarkissian, M.; Mu, Z. Y.; Scher, H. I.; Lesokhin, A. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Targeting the androgen receptor in prostate and breast cancer: Several new agents in development
    Journal Article

    Proverbs-Singh, T.; Feldman, J. L.; Morris, M. J.; Autio, K. A.; Traina, T. A.
    Endocrine-Related Cancer (2015)

    Fulltext@MSK | Save